The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.05 (1.49%)
Spread: 0.20 (6.061%)
Open: 3.35
High: 3.40
Low: 3.35
Prev. Close: 3.35
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Sluggish open ahead of US Fed testimony this week

Mon, 06th Mar 2023 09:04

(Alliance News) - London's equities got off to a slow start on Monday, lagging behind more positive trading in Europe and Friday's rally on Wall Street.

Indices were mixed. The FTSE 100 index opened down 2.38 points at 7,944.73, amid strength in the pound. The FTSE 250 was up 26.01, 0.1%, at 19,951.78 and the AIM All-Share was down 2.27 points, 0.3%, at 862.70.

The Cboe UK 100 was down 0.1% at 795.12, the Cboe UK 250 was up 0.1% at 17,501.45, and the Cboe Small Companies was down 0.2% at 14,137.36.

"UK markets were slow to the latest party, with a tepid opening which reflected a lack of immediate catalysts," said interactive investor's Richard Hunter.

In Paris, the CAC 40 index was up 0.4%. In Frankfurt, the DAX 40 was up 0.2%.

The week ahead will be a consequential one for US economic data and monetary policy guidance.

Before the key US jobs report on Friday, Federal Reserve Chair Jerome Powell will testify before Congress on Tuesday and Wednesday.

"It's unlikely that he will give too many clues given how close to the next meeting we are, and the main takeaway is likely to be data dependence, however, don't be surprised if markets pore over every single nuance just so that they can reinforce their own particular mindset," said CMC Markets' Michael Hewson.

The next Federal Open Market Committee policy-making meeting is on March 21 and 22.

The dollar was softer against major currencies in early exchanges.

Sterling was quoted at USD1.2040 early Monday, firming from USD1.1979 at the London equities close on Friday. The euro traded at USD1.0650, higher than USD1.0601. Against the yen, the dollar was quoted at JPY135.81, down versus JPY136.21.

Wall Street rallied on Friday, with the Dow Jones Industrial Average ending up 1.2%, the S&P 500 up 1.6%, and the Nasdaq Composite up 2.0%.

In the UK, Prime Minister Rishi Sunak unveiled a new plan for the country to become a science and technology "superpower" by the end of the decade.

Funding of more than GBP360 million has been promised by the UK government, as the prime minister hopes a science and technology framework will place the UK at the forefront of new technologies including artificial intelligence and supercomputing.

Meanwhile, the UK government faced criticism from the oil and gas sector. In an interview with the Times, Shell's new chief executive, Wael Sawan, said the US is more attractive for energy investment than the UK.

Sawan told the newspaper that the UK government should look to the US's recent actions, such as the 'inflation reduction act', which gives a USD369 billion subsidy package to encourage domestic green investment.

Sawan said he would "think twice" about further oil investment in the UK, citing "more attractive" propositions, such as the US Gulf of Mexico.

Recent developments in the UK such as ad-hoc interventions, delays to planning, and a lack of clarity over subsidies are likely to hinder Shell's goal to invest GBP25 billion in the UK over the next decade, he said.

Shares in Shell were up 0.4%. Peer BP was up 0.3%.

Brent oil was trading at USD85.20 a barrel early Monday, little changed from USD85.34 on Friday. Gold was quoted at USD1,853.42 an ounce, higher than USD1,845.56.

In Asia on Monday, the Nikkei 225 index in Tokyo closed up 1.1%. The S&P/ASX 200 in Sydney closed up 0.6%.

China's economy is expected to grow "around 5%", outgoing Chinese Premier Li Keqiang said as he opened this year's National People's Congress in Beijing. Last year's growth target was around 5.5%.

The focus of the annual week-long meeting of hand-picked delegates is the approval of the planned formation of a new government and the setting of the country's economic and political course.

China also plans to increase its military spending by 7.2% this year in response to geopolitical uncertainties, according to a draft budget.

"The path to economic reopening could be bumpy with the potential for further spikes in Covid infections on the mainland and issues surrounding its embattled property sector, prompting some investors to remain cautious towards China," ii's Victoria Scholar.

The cautious growth projections suggest the Chinese government is taking a "vigilant approach", she added.

In China, the Shanghai Composite fell 0.2%, while the Hang Seng index in Hong Kong added 0.2%.

Back in London, FTSE 250-listing Aston Martin jumped 24% to 296.60 pence, as Jefferies raised the target price for the stock to 160p from 120p.

Last Wednesday, the luxury carmaker hailed its "strongest order book in many years", alongside its annual results.

Clarkson rose 4.5%.

The shipping services provider raised its shareholder payout for the 20th year in a row, amid a "record" performance.

In 2022, revenue jumped to GBP603.8 million from GBP443.3 million. Pretax profit increased to GBP100.1 million from GBP69.1 million.

The firm increased its final dividend to 64p from 57p, resulting in a full-year payout of 93p, up from 84p. "

"Whilst the global geo-political outlook for 2023 and beyond remains uncertain, the strength of business and balance between supply and demand, supported by our record level of forward order book, gives us confidence in the outlook for Clarksons," said CEO Andi Case.

Among London small-caps, Foxtons added 2.0%.

The London-based estate agent firm confirmed the acquisition of Atkinson McLeod for GBP7.4 million, to be funded from its existing cash reserves. Atkinson McLeod is an estate agent operating in Central East London, with four branches, bringing in around 90% of its revenue from around 1,100 tenancies.

The acquisition, intended to bolster Foxtons' letting business, is expected to be accretive to earnings this year, it said. Monday's announcement confirmed a report by Sky News on Sunday.

On AIM, Fusion Antibodies plunged 26%.

The antibody developer said revenue and earnings for the year ending March 31 are expected to be "significantly" behind market expectations, with revenue to be no less than GBP2.8 million.

This is due continuing uncertainty over the timing of several anticipated orders, which is outside the firm's control.

As Fusion shifts its focus on larger integrated service contracts, it notes "very positively received" discussions with several potential clients.

Still to come on Monday's economic calendar, the latest UK construction purchasing managers' index is due at 0930 GMT.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
30 Apr 2024 19:54

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 Apr 2024 13:29

Fusion Antibodies inks commercial contract for OptiPhage library

(Alliance News) - Fusion Antibodies PLC on Monday said that it has signed a commercial contract to develop an OptiPhage library for a non-human antibody species.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Feb 2024 13:15

Fusion Antibodies gets first order under new services agreement

(Sharecast News) - Fusion Antibodies announced the receipt of its first purchase order under a master services agreement on Tuesday, which it agreed with a prominent diagnostics company on 14 February.

Read more
14 Feb 2024 12:52

Fusion Antibodies raises £1.38m as it seeks new customers

(Sharecast News) - Pre-clinical antibody specialist Fusion Antibodies announced a conditional fundraising of £1.38m before expenses on Wednesday, to help it target mo re industry conferences and customers and generate further supporting data.

Read more
14 Feb 2024 11:27

IN BRIEF: Fusion Antibodies raises GBP1.4 million via placing

Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4 million before expenses via placing of 34.4 million shares at 4 pence each. The issue price represents a discount of 5.9% to Fusion's closing mid-market share price on Tuesday. Further, it intends to issue 1.5 million new shares to certain directors in lieu of or in satisfaction of salary and fees due to them and which shall be issued immediately following publication of its announcement. Also intends to grant a total of up to 3.8 million new share options to staff and senior management.

Read more
6 Feb 2024 11:48

Fusion Antibodies strikes follow-on research and development project

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company".

Read more
6 Feb 2024 10:05

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
1 Feb 2024 16:27

Fusion Antibodies confirms £0.28m tax credit

(Sharecast News) - Preclinical antibody discovery specialist Fusion Antibodies announced the successful receipt of a research and development tax credit from HMRC on Thursday.

Read more
1 Feb 2024 12:00

Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform

(Alliance News) - Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other projects in bioinformatics.

Read more
4 Dec 2023 16:56

LONDON MARKET CLOSE: FTSE 100 slips as miners hold down index

(Alliance News) - Stock prices in London closed lower on Monday, with miners and oil firms holding down the FTSE 100 index.

Read more
4 Dec 2023 12:01

Fusion Antibodies revenue falls, losses widen in first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenue of £0.54m on Monday, down from £1.9m a year earlier.

Read more
4 Dec 2023 10:23

AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
4 Dec 2023 10:22

Fusion Antibodies shares fall with revenue despite "positive" outlook

(Alliance News) - Fusion Antibodies PLC on Monday reported a widened loss and reduced revenue for its latest half year, but said its growth prospects are "increasingly positive".

Read more
28 Nov 2023 12:09

Fusion Antibodies shares up on deal with US National Cancer Institute

(Alliance News) - Fusion Antibodies PLC on Tuesday said it has signed a collaboration agreement with the US National Cancer Institute to use its OptiMAL product to discover novel antibodies to treat certain targets.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.